TITLE

The Industry Backs Tough Standards

PUB. DATE
February 2011
SOURCE
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p76
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the support of the Generic Pharmaceutical Association (GPhA) representing generic drug suppliers, for the Food and Drug Administration's (FDA) efforts in maintaining a stringent approval process for generic medications in the U.S.
ACCESSION #
59994656

 

Related Articles

  • Speedy delivery: Bringing generics to market faster. MONKS, RICHARD // Drug Store News;10/20/2014, Vol. 36 Issue 10, p46 

    The article reports regulatory developments in the pharmaceutical sector in the U.S. as of late October 2014, particularly involving generic drugs. It cites the efforts by the Food and Drug Administration (FDA) and the Generic Pharmaceutical Association (GPhA) in finding ways to facilitate the...

  • Generic User Fee Legislation Moves Forward.  // Chain Drug Review;7/16/2012, Vol. 34 Issue 12, p62 

    The article reports that final congressional approval of the user fee proposals that were recently negotiated by the Generic Pharmaceutical Association (GPhA) and the U.S. Food and Drug Administration has won applause from the pharmaceutical industry.

  • GPhA: FDA Needs More Resources.  // Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p68 

    The article reports that the Generic Pharmaceutical Association (GPhA) is recognizing that member companies' products will be moving expeditiously if the Food and Drug Administration (FDA) has sufficient resources in reviewing the Abbreviated New Drug Applications in the U.S.

  • Regulatory Workshop Set By FDA, GPhA.  // Chain Drug Review;4/23/2012, Vol. 34 Issue 8, p250 

    The article offers information on the U.S. Food and Drug Administration (FDA) and Generic Pharmaceutical Association's two day workshop to be held in Bethesda, Maryland on May 22-23, 2012.

  • GPhA responds to possibility of more stringent FDA regulations. DeArment, Alaric // Drug Store News;11/15/2010, Vol. 32 Issue 14, p29 

    The article focuses on the response of the Generic Pharmaceutical Association (GPhA) to the U.S. Food and Drug Administration's (FDA) adoption of tougher standards for certain classes of generic drugs.

  • GPhA concerned about FDA's proposed labelling changes.  // Reactions Weekly;Feb2014, Vol. 1488 Issue 1, p4 

    The article discusses the concerns of the Generic Pharmaceutical Association (GPhA) on the proposed drug labeling amendments to the "Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products" issued by the U.S. Food & Drug Administration in November 2013.

  • Prescribing Info May Go Electronic.  // Chain Drug Review;2/16/2015, Vol. 37 Issue 4, p78 

    The article reports that a rule proposed by the U.S. Food and Drug Administration, which would need manufacturers of prescription drugs to distribute product labeling information to health care providers electronically has been supported by the Generic Pharmaceutical Association (GPhA).

  • Congress to debate flurry of controversies surrounding generic drug regulation. Wechsler, Jill // Formulary;Feb2001, Vol. 36 Issue 2, p168 

    Updates on developments relating to controversies surrounding generic drug regulation in the United States. Congress' examination of whether to revise the Food and Drug Administration's rules for generic products testing and review; Prescription Drug User Fee Act; Plans for legislation to limit...

  • Mythbusters: FDA's take on Generic Drugs.  // Grand Saline Sun (TX);8/13/2009, Vol. 113 Issue 32, p6 

    The article focuses on the policy the Food and Drug Administration (FDA) on generic drugs in the U.S.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics